Ceramide C22:0 to sphingomyelin C26:0 ratio

Biomarker1 paper1 finding

  • Humans1

Effects

1

Cognitive impairment

mediatesin humans1

1 study
  1. Ceramide C22:0 to sphingomyelin C26:0 ratio mediates cognitive impairment in humans (proportion mediated = -14.3%).

    HumansHumidexmean-CI association

    Associations between compound heat exposure and cognitive impairment and the potential mediating role of plasma sphingolipid metabolites: Evidence from a large-scale population cohort study · Environmental pollution (Barking, Essex : 1987) · 17 Sep 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01